FEMITONE Trademark

Trademark Overview

On Monday, September 14, 2020, a trademark application was filed for FEMITONE with the United States Patent and Trademark Office. The USPTO has given the FEMITONE trademark a serial number of 90180165. The federal status of this trademark filing is REGISTERED as of Tuesday, April 19, 2022. This trademark is owned by Alura, Inc.. The FEMITONE trademark is filed in the Medical Instrument Products category with the following description:

radio frequency medical devices for increasing blood flow for body contouring, and fat and cellulite reduction
femitone

General Information

Serial Number90180165
Word MarkFEMITONE
Filing DateMonday, September 14, 2020
Status700 - REGISTERED
Status DateTuesday, April 19, 2022
Registration Number6708185
Registration DateTuesday, April 19, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 22, 2020

Trademark Statements

Goods and Servicesradio frequency medical devices for increasing blood flow for body contouring, and fat and cellulite reduction

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, October 21, 2020
Primary Code010
First Use Anywhere DateWednesday, December 1, 2021
First Use In Commerce DateWednesday, December 1, 2021

Trademark Owner History

Party NameAlura, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHouston, TX 77040
Party NameAlura, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77040
Party NameAlura, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77040

Trademark Events

Event DateEvent Description
Tuesday, April 19, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, March 12, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 11, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 11, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 16, 2022USE AMENDMENT FILED
Thursday, March 10, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 16, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, August 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 16, 2021SOU EXTENSION 1 GRANTED
Monday, August 16, 2021SOU EXTENSION 1 FILED
Monday, August 16, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 19, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, November 19, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 19, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, November 19, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, November 19, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, November 18, 2020ASSIGNED TO LIE
Wednesday, November 18, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 18, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, November 18, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 18, 2020ASSIGNED TO EXAMINER
Wednesday, October 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 17, 2020NEW APPLICATION ENTERED

Related Keywords

femitone body contouring cellulite reduction flow blood frequency medical devices increasing